-65.7%
MRNA vs MET
+83.9%
-149.6%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MET | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.4% | +5.0% | +5.2% |
| 7D | -1.1% | -0.5% | -0.6% | -0.9% |
| 30D | +126.1% | +0.5% | +125.6% | +124.9% |
| 3M | +190.0% | +11.6% | +178.4% | +172.9% |
| 6M | +157.2% | +40.8% | +116.4% | +115.3% |
| YTD | +388.2% | +25.7% | +362.5% | +329.4% |
| 1Y | +467.0% | +24.4% | +442.7% | +400.6% |
| 3Y | +36.1% | +67.5% | -31.4% | +2.2% |
| All | -65.7% | +83.9% | -149.6% | -74.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MET.
Daily Out/Under-Performance
Portfolio return minus MET return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MET return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MET wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling